
1. malar j. 2017 feb 2;16(1):61. doi: 10.1186/s12936-017-1687-1.

genetic diversity plasmodium vivax metacaspase 1 plasmodium vivax
multi-drug resistance 1 genes field isolates mauritania, sudan oman.

sow f(1), bonnot g(2), ahmed br(3), diagana sm(3), kebe h(4), koita m(5), samba
bm(6), al-mukhaini sk(7)(8), al-zadjali m(7)(8), al-abri ss(7)(8), ali oa(7)(8), 
samy am(9)(10), hamid mm(11), ali albsheer mm(11), simon b(2)(12), bienvenu
al(2)(12), petersen e(7)(8)(13), picot s(2)(12).

author information: 
(1)institut de chimie et biochimie moléculaires et supramoléculaires
icbms-umr5246, cnrs-insa-cpe, malaria research unit, university claude bernard
lyon 1, 43 boulevard du 11 novembre 1918, lyon, 69622, villeurbane, france.
fatimata.sow@etu.univ-lyon1.fr.
(2)institut de chimie et biochimie moléculaires et supramoléculaires
icbms-umr5246, cnrs-insa-cpe, malaria research unit, university claude bernard
lyon 1, 43 boulevard du 11 novembre 1918, lyon, 69622, villeurbane, france.
(3)laboratoire de bactériologie et parasitologie de l'hôpital cheikh zayed,
bp-5720, nouakchott, mauritania.
(4)service des maladies infectieuses et tropicales, centre hospitalier national
de nouakchott, bp-612, nouakchott, mauritania.
(5)laboratoire de parasitologie et de mycologie médicale institut national de
recherches en santé publique (inrsp), avenue jemal abdenasser, bp-695,
nouakchott, mauritania.
(6)laboratoire analyse de biologie médicale du centre hospitalier de rosso
mauritanie, bp-41, rosso, mauritania.
(7)department infectious diseases, royal hospital, muscat, oman.
(8)department malaria, ministry health, muscat, oman.
(9)entomology department, faculty science, shams university, abbassia,
cairo, 11566, egypt.
(10)biodiversity institute, university kansas, lawrence, ks, 66045, usa.
(11)department parasitology medical entomology, institute endemic
diseases, medical campus, university khartoum, qassr street, p.o. box 102,
khartoum, sudan.
(12)institut parasitology medical mycology, hôpital de la croix-rousse,
hospices civils de lyon, lyon, france.
(13)institute clinical medicine, faculty health science, university of
aarhus, aarhus, denmark.

background: plasmodium vivax second important human malaria parasite,
widely spread across world. parasite associated important issues
in process toward malaria elimination, including potential relapse and
increased resistance chloroquine. plasmodium vivax multi-drug resistant
(pvmdr1) suspected marker resistance although definitive evidence
is lacking. progress made knowledge biological factors affecting
parasite growth, including mechanisms regulated cell death suspected
role metacaspase. plasmodium vivax metacaspase1 (pvmca1-cd) described
with catalytic domain composed histidine (h372) cysteine (c428)
residues. aim study test link conserved
histidine cysteine residues pvmca1-cd, polymorphism p.
vivax multi-drug resistant gene (pvmdr1).
results: thirty p. vivax isolates collected mauritania, sudan, and
oman. among 28 p. vivax isolates successfully sequenced, 4 samples
showed conserved (372)-cys (428) residues pvmca1-cd. single nucleotide
polymorphisms observed h372t (46.4%), h372d (39.3%), c428r (85.7%). a
new polymorphic catalytic domain observed (282)-cys (305) residues.
sequences alignment analysis pvmdr1 showed snp three codons 958, 976
and 1076. single snp identified codon m958y (60%), 2 snps found
at position 976: y976f (13%) y976v (57%), 3 snps identified at
the position 1076: f1076l (40%), f1076t (53%) f1076i (3%). one isolate
was wildtype three codons (myf), 27% single myl mutants, 10% were
double mfl mutants. three new haplotypes also identified: triple mutant 
yvt prevalent (53.3%) distributed three countries, triple
yfl yvi mutants (3%), found samples sudan mauritania.
conclusions: triple quadruple mutants metacaspase genes double or
triple mutants pvmdr1 observed 24/28 19/28 samples. 
difference frequency mutations pvmca1-cd pvmdr1 (p > 0.2). 
histidine cysteine residues pvmca1-cd highly polymorphic linkage
disequilibrium snps pvmdr1 gene may expected three areas
with different patterns p. vivax transmission.

doi: 10.1186/s12936-017-1687-1 
pmcid: pmc5288979
pmid: 28153009  [indexed medline]

